2 Hims & Hers has been one of the most prominent players in the direct-to-consumer GLP-1 space, yet the company has faced its own headwinds in recent months after being required to pull access to compounded semaglutide following FDA action against mass compounding of GLP-1 drugs
Mounjaro has been on the FDA's shortage list since the latter part of 2022, and Zepbound was added in April of 2024
Each receptor contributes a different piece: GLP-1 reduces appetite and slows digestion GIP improves insulin sensitivity and fat metabolism Glucagon increases energy expenditure and fat breakdown The result is up to 24% average weight loss in Phase 2 trials, with Phase 3 data showing even higher numbers (28.7% at 68 weeks)
When I first looked into Retatrutide about eight months ago, the allergic reaction question was top of mind for me
GLP-1 Weight-Loss Drugs Prove Effective Across Diverse Patient Groups
L-Carnitine for Weight Loss: Benefits, Uses & Science L-Carnitine for Weight Loss: Benefits, Uses & Science By Dr